January column from the Editor-in-Chief
Joseph I. Sirven, M.D.
Happy New Year! January is a time of reflection, hope and excitement for what is to come over the next twelve months. Here at Epilepsy.com Professionals we are engaged and very enthusiastic as to what the New Year promises to bring in our fight against seizures and epilepsy. As we start the New Year, this is a traditional time for new years’ resolutions. I was recently asked about my New Year’s resolution and I replied that I would resolve to better listen to my patients . Listening is an active process that involves taking into account body posture, facial cues, the voice and what is actually being said. I think for all physicians we find ourselves in a situation that sometimes as the clinic day grows busier and the time allowed for our patient visits grows shorter, it gets more difficult to conduct active listening and truly understand what the person in front of us is telling us.
As I resolve to keep this resolution of better listening to our patients I am reminded that there are so many issues that really have risen to the forefront as 2010 dawns that we really need to pay close attention to. As was recently noted immediately prior to the Christmas holidays, the Senate passed a historic healthcare reform bill. Many details are written in this thousand page tome yet little is truly understood of how it will impact those patients who suffer from epilepsy and seizures. My only hope and prayer is that as we see what is passed in healthcare reform that the act of being able to sit, talk and listen to your patients is optimized and not hurt by whatever is changed in healthcare reform.
As we look to the future on epilepsy.com, much is happening over the course of the winter of 2010 that will help you as a professional care for your patients with epilepsy. As you will note, we have, in collaboration with the American Epilepsy Society, hosted a convenient link to Epilepsy Currents, the American Epilepsy Society’s journal. Epilepsy Currents provides an up to date review of the latest basic science and clinical epilepsy research. We hope that its placement on the Epilepsy.com Professionals page will serve as an excellent access point to those who want to see what the latest in research is. In addition, our Hallway Conversations continue over the course of January. On January 13 Dr. Lisa Bateman from the University of California Davis in Sacramento, California, discusses her groundbreaking research on how to prevent diminished oxygen intake or hypoxemia during seizures especially in a monitoring unit admission. On January 27, 2010 Dr. John Stern from the University of California, Los Angeles, joins us to discuss his work on how to improve patient-physician communications, the outcome of a Phase 2 study regarding antiepileptic drugs and their mood-adverse effects.
Lastly, there are many other items on Epilepsy.com that we hope you will find interesting and enjoyable. My Epilepsy Diary is gaining traction and popularity as a new tool to help professionals as well as their patients track their seizures and response to medications. We also have an upcoming CME course in San Francisco in late February furthering the latest information on epilepsy therapies that display promise. We hope you find this information helpful so that you may better improve the quality of life of your patients.
Joseph Sirven, M.D.
A personal invitation for you to attend the 2010 Pipeline CNS Conference
The 2010 Epilepsy Pipeline Update Conference continues the tradition of showcasing new and promising treatments. This day will focus on preclinical, early- and late-stage clinical development strategies, and investment and business development opportunities. See http://www.epilepsy.com/etp/pipeline2010.
Why Attend the Epilepsy Pipeline Conference?
This in-depth, 2 day meeting showcases emerging companies and scientific entrepreneurs alongside established companies presenting their strategies, candidates and development programs. New anti-epilepsy products, in particular, are known to provide the optimal pathway for CNS therapeutic development with well-characterized mechanisms, therapeutic approaches, functional models and well-defined clinical endpoints for regulatory studies.
Thoughtfully selected by Epilepsy Therapy Project’s expert Scientific and Business Advisory Boards, presenters will cover the most innovative and intriguing therapeutic targets and programs in development today for epilepsy - with potential for broader CNS applications. Hear insights from scientific, clinical and industry leaders relevant to investment in epilepsy and broader CNS areas. Recent advances, creating remarkable investment and commercial opportunities, require expert perspective on risk profile, clinical advantages and product lifecycle management.
We hope you will join us for this enriched 2 day opportunity:
More details are available on the epilepsy.com website. Please be sure to register and join us.
© 2013 Epilepsy.com. All rights reserved.